Patents Assigned to U & I Pharmaceuticals Ltd.
-
Patent number: 7022698Abstract: Pharmaceutical compositions containing Form III, Form IV, Form V olanzapine and/or pharmaceutically acceptable salts thereof. The pharmaceutical compositions are useful for the treatment of psychotic conditions, mild anxiety and gastrointestinal conditions. In particular, the compositions are useful for treating schizophrenia and related disorders, acute mania, Bipolar I Disorder, psychotic mood disorder and psychosis in patients with Alzheimer's disease.Type: GrantFiled: December 27, 2001Date of Patent: April 4, 2006Assignee: U & I Pharmaceuticals, Ltd.Inventors: Yusuf K. Hamied, Rajendra N. Kankan, Dharmaraj R. Rao
-
Patent number: 7011847Abstract: Pharmaceutical compositions and methods of using the composition are provided. The pharmaceutical composition comprises an inert core surrounded by an active coating containing one or more bisphosphonic acids or salts thereof, a seal coating surrounding the active coating and an enteric coating surrounding the seal coating. Alendronic acid and alendronate sodium trihydrate are the preferred active ingredients. The composition may be provided in the form of pellets in a capsule or Peltabs. The invention further provides methods for the treatment of disorders caused by the abnormal dissolution or deposition of calcium salts using the inventive compositions.Type: GrantFiled: October 16, 2003Date of Patent: March 14, 2006Assignee: U & I Pharmaceuticals Ltd.Inventors: Amar Lulla, Geena Malhotra
-
Patent number: 6962691Abstract: A topical, medicinal spray composition is provided comprising a drug or combination of drugs in a carrier which, when sprayed on a surface, forms a film. The composition comprises at least one medicament, at least one film former and at least one vehicle. The composition of the invention may further comprise at least one permeation enhancer, at least one solubilizer, at least one plasticizer, and at least one water soluble additive. A metered dose of the composition can be sprayed on a topical site to form a stable, breathable film, preferably over a fixed surface area. A wide range of medicaments for human and veterinary use may be present that act locally or transdermally.Type: GrantFiled: February 15, 2000Date of Patent: November 8, 2005Assignee: U & I Pharmaceuticals Ltd.Inventors: Amar Lulla, Geena Malhotra, Preeti Raut
-
Publication number: 20040213744Abstract: A topical, medicinal spray composition is provided comprising a drug or combination of drugs in a carrier which, when sprayed on a surface, forms a film. The composition comprises at least one medicament, at least one film former and at least one vehicle. The composition of the invention may further comprise at least one permeation enhancer, at least one solubilizer, at least one plasticizer, and at least one water soluble additive. A metered dose of the composition can be sprayed on a topical site to form a stable, breathable film, preferably over a fixed surface area. A wide range of medicaments for human and veterinary use may be present that act locally or transdermally.Type: ApplicationFiled: October 16, 2003Publication date: October 28, 2004Applicant: U & I Pharmaceuticals Ltd.Inventors: Amar Lulla, Geena Malhotra, Preeti Raut
-
Publication number: 20040161460Abstract: Pharmaceutical compositions and methods of using the composition are provided. The pharmaceutical composition comprises an inert core surrounded by an active coating containing one or more bisphosphonic acids or salts thereof, a seal coating surrounding the active coating and an enteric coating surrounding the seal coating. Alendronic acid and alendronate sodium trihydrate are the preferred active ingredients. The composition may be provided in the form of pellets in a capsule or Peltabs. The invention further provides methods for the treatment of disorders caused by the abnormal dissolution or deposition of calcium salts using the inventive compositions.Type: ApplicationFiled: October 16, 2003Publication date: August 19, 2004Applicant: U & I PHARMACEUTICALS LTD.Inventors: Amar Lulla, Geena Malhotra
-
Patent number: 6676965Abstract: Pharmaceutical compositions, processes for preparing the compositions and methods of using the composition are provided. The pharmaceutical composition comprises an inert core surrounded by an active coating containing one or more bisphosphonic acids or salts thereof, a seal coating surrounding the active coating and an enteric coating surrounding the seal coating. Alendronic acid and alendronate sodium trihydrate are the preferred active ingredients. The composition may be provided in the form of pellets in a capsule or Peltabs. The invention further provides methods for the treatment of disorders caused by the abnormal dissolution or deposition of calcium salts using the inventive compositions.Type: GrantFiled: September 26, 2000Date of Patent: January 13, 2004Assignee: U&I Pharmaceuticals Ltd.Inventors: Amar Lulla, Geena Malhotra
-
Patent number: 6348458Abstract: The invention provides three new polymorphic forms of 2-methyl-4-[4-methyl-1-piperazinyl]-10H-thieno[2,3b][1,5]benzodiazepine (Olanzapine) (Formula A), the process for preparing the new polymorphs and pharmaceutical compositions containing the polymorphs. The new polymorphic forms of olanzapine are useful for the treatment of psychotic conditions, mild anxiety and gastrointestinal conditions.Type: GrantFiled: March 31, 2000Date of Patent: February 19, 2002Assignee: U & I Pharmaceuticals Ltd.Inventors: Yusuf K. Hamied, Rajendra N. Kankan, Dharmaraj R. Rao